Advances on Resources, Biosynthesis Pathway, Bioavailability, Bioactivity, and Pharmacology of Robustaflavone

Quanyong Wu; Boya Ouyang; Mohamed A. Farag; Miguel A. Prieto; Hui Cao; Jesus Simal Gandara

doi:10.1007/978-3-030-94753-8_69-1

Back

Advances on Resources, Biosynthesis Pathway, Bioavailability, Bioactivity, and Pharmacology of Robustaflavone

Chapter In A Book 2023 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2024

Advances in resources, biosynthesis pathway, bioavailability, bioactivity, and pharmacology of ochnaflavone

Shiye Lin, Abirami Ramu Ganesan, Celia Vargas‐De‐La‐Cruz, Jaime Ortíz, Jianbo Xiao

Article2022

Recent advances in the biosynthesis, bioavailability, toxicology, pharmacology, and controlled release of citrus neohesperidin

Saima Akhter, Md. Saiful Islam Arman, Mohammed Abu Tayab, Mohammad Nazmul Islam, Jianbo Xiao

Chapter in a book2023

Myricitrin: Resources, Bioavailability, Bioactivity, and Potential Applications

Yaqian Geng, Yingfeng Xie, Yiran Yu, Wei Li, Yao Mou, Fang Chen, Jianbo Xiao, Xiao Hu, Junfu Ji, Lingjun Ma

Article2021

Advances on delta 5-unsaturated-polymethylene-interrupted fatty acids: Resources, biosynthesis, and benefits

Lili Song, Sisi Wen, Qin Ye, Heqiang Lou, Yadi Gao, Vivek K. Bajpai, María Carpena, Miguel A. Prieto, Jesus Simal Gandara, Jianbo Xiao, Xianghe Meng, Jiasheng Wu

Article2022

Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin

Ruting Zhong, Mohamed A. Farag, Meiwan Chen, Chengwei He, Jianbo Xiao